Gaurav Munj 2022-03-04T06:42:16+00:00 CREATING SHAREHOLDER VALUE Site - Investor Relations Nav Overview Press Releases Events and Presentations Financial Filings Stock Information Corporate Governance Contact Upcoming and Recent Events Corporate Presentation SEC Filings Stock Quote & Chart Historical Lookup Governance Documents Committees Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. Latest Press Releases November 12, 2024 Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments October 2, 2024 Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares View All Press Releases View All Events September 23, 2024 at 8:30 AM EDT Biohaven Topline Pivotal Trial Results for Troriluzole in Spinocerebellar Ataxia Listen to webcast May 29, 2024 Biohaven R&D Day at Yale School of Management May 31, 2023 Biohaven R&D Day at Yale School of Management View All Events View All BIOHAVEN EVENTSCORPORATE PRESENTATION LETTER FROM THE CHAIRMAN & CEO VIDEOS play video INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY x play video Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money x play video Diseases related to glutamate dysregulation x
Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas including neuroscience, immunology and oncology. Latest Press Releases November 12, 2024 Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments October 2, 2024 Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares View All Press Releases View All Events September 23, 2024 at 8:30 AM EDT Biohaven Topline Pivotal Trial Results for Troriluzole in Spinocerebellar Ataxia Listen to webcast May 29, 2024 Biohaven R&D Day at Yale School of Management May 31, 2023 Biohaven R&D Day at Yale School of Management View All Events View All BIOHAVEN EVENTSCORPORATE PRESENTATION LETTER FROM THE CHAIRMAN & CEO VIDEOS play video INTERVIEW WITH CEO VLAD CORIC M.D. ON CNBC’S FAST MONEY x play video Interview with CEO Vlad Coric M.D. on CNBC’s Mad Money x play video Diseases related to glutamate dysregulation x
November 12, 2024 Biohaven Reports Third Quarter 2024 Financial Results and Recent Business Developments
October 2, 2024 Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
September 23, 2024 at 8:30 AM EDT Biohaven Topline Pivotal Trial Results for Troriluzole in Spinocerebellar Ataxia Listen to webcast